Women’s Health Diagnostics Market

Global Women’s Health Diagnostics Market Size, Share, Development, Growth and Demand Forecast to 2023

Delivery : 24-72 Working Hours
Report Code: LS10816
Available Format:

The global women’s health diagnostic market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing incidence of lifestyle diseases in women and growing awareness among women about various health disorders. Moreover, growing prevalence of infectious diseases in women including hepatitis and HIV is supporting the growth of the market. Based on application, the prenatal genetic screening and carrier test segment is expected to grow at the fastest rate during the forecast period. The increasing awareness about these tests is driving the growth of this segment.

The rapid growth in emerging economies with increasing number of diagnostic and imaging centers and increasing adoption of point-of-care diagnostic testing drives the growth of the market. However, high cost of diagnostic imaging systems and procedures, and shortage of skilled laboratory technicians are the key restraints hampering the growth of the global market.

As per the United Nations Department of Economic and Social Affairs (UN-DESA) report on the global aging population, the population of people aged 60 years or above is growing with high rate. In 2013, the global share of people aged 60 or above was 11.7% and it is expected to reach 21.1% by the end of 2050. Further, the number of people aged 60 years and above is expected to reach approximately 437 million in China, 324 million in India, 107 million in the U.S. and 58 million in Brazil by 2050. The increase in geriatric pool supports the market growth as aged people have weakened body functions, impaired blood circulation and are more susceptible to chronic diseases.

Geographically, North America has been the largest market for women’s health diagnostic owing to increased awareness, established healthcare industry, and increasing prevalence of cancer in this region. The U.S. contributed largest revenue to the North American as well as global women’s health diagnostic market. The increasing incidence of lifestyle related health disorders and increasing demand for fertility test is the key growth driving factor of the U.S. women’s health diagnostic market.

Europe has been the second largest market for women’s health diagnostic, where the market is driven by the presence of a large pool of cancer patients, increasing healthcare expenditure and rapidly developing healthcare infrastructure. In 2015, Germany led the European women’s health diagnostic market and it is also expected to grow at the fastest rate in Europe, during forecast period. Globally, the women’s health diagnostic market in Asia-Pacific is expected to witness highest growth during the forecast period. The highest growth in the region is attributed to the increasing prevalence of chronic diseases, increasing per capita income leading to increasing standard of living, increasing healthcare spending, growing demand for better quality medical care, and awareness about women’s health diagnostic tests in the region.

The key players operating in the global women’s health diagnostic market are F. Hoffmann-LA Roche AG, Siemens AG, Hologic, Inc., Quest Diagnostics Inc., Alere Inc., Perkinelmer, Inc., GE Healthcare, Koninklijke Philips N.V., Abbott Laboratories, Becton, Dickinson and Company and Biomérieux SA.

By Application

  • Osteoporosis Test
    • Bone Densitometry
    • In Vitro Blood Test
  • Breast Cancer Test
    • Mammography
    • Breast Cancer Tumor Marker Test
    • Blood Chemistries and Blood Cell Count Test
    • Biopsies
    • Others
  • Ovarian Cancer Test
    • Ovarian Cancer Tumor Marker Test
    • Diagnostic Imaging Test
    • Others
  • Cervical Cancer Test
    • PAP Smear
    • HPV Test
  • Pregnancy and Fertility Test
    • Lab-Based Test
    • Pregnancy Testing and Ovulation Prediction Kits
    • Fertility Monitors
  • Prenatal Genetic Screening and Carrier Test
    • Cystic Fibrosis
    • Down Syndrome and Edwards Syndrome
    • Torch Infections
    • Other Diseases
  • Infectious Disease Test
    • MRSA Test
    • Urinary Tract Infection Test (Vaginal Ph & Vaginitis)
    • Hepatitis Test
    • Tuberculosis Test
    • Others
  • Sexually Transmitted Disease Test
    • Chlamydia Trachomatis and Neisseria Gonorrhoeae Test
    • HIV Test
    • Other Sexually Transmitted Diseases
  • Ultrasound Test
    • Breast Imaging
    • Obstetrics/ Gynecology Imaging

By End User

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World (RoW)
    • Brazil
    • Rest of RoW

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 5100
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 6100
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 9100

Pre-Purchase Enquiry